Steven J Weissbart1, Dasha Pechersky2, Anna Malykhina3, Thomas Bavaria4, Lisa Parrillo4, Lily A Arya1, Michel Bilello2, Alan J Wein4, Ariana L Smith4. 1. Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, Pennsylvania. 2. Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania. 3. Division of Urology, Department of Surgery, University of Colorado, Aurora, Colorado. 4. Division of Urology, Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract
AIMS: To investigate the relationship between pontine lesion characteristics on MRI and lower urinary tract symptoms (LUTS) in patients with multiple sclerosis (MS). METHODS: We performed a prospective cohort study of patients with MS and LUTS who were undergoing brain/spine MRI. Patients were administered the American Urological Association Symptom Score (AUA-SS), Medical, Epidemiologic, and Social Aspects of Aging questionnaire (MESA), and Urogenital Distress Inventory questionnaire (UDI-6), underwent Kurtzke Expanded Disability Status Scale (EDSS) scoring by a neurologist, and had their MRIs reviewed by a neuroradiologist. The relationships between symptom scores and lesion number, size, and location were analyzed. RESULTS: There were 42 patients that completed the study and 20 (48%) had one or more pontine lesions. Total AUA-SS and UDI-6 were related to multiple Short Form Health Survey (SF-36) scales and not EDSS scoring. Weak urinary stream measured on the AUA-SS (P = 0.028), and urgency incontinence measured on the MESA questionnaire (P = 0.034) were related to pontine lesion diameter. There was no difference in urinary symptoms according to the presence or absence of a pontine lesion, or according to lesion location within the pons. CONCLUSIONS: Pontine lesion size appears to be related to lower urinary tract symptoms (weak stream and urgency incontinence) in patients with MS. Therefore, CNS lesion characteristics may be able to phenotype voiding symptoms in patients with MS. Neurourol. Urodynam. 36:453-456, 2017.
AIMS: To investigate the relationship between pontine lesion characteristics on MRI and lower urinary tract symptoms (LUTS) in patients with multiple sclerosis (MS). METHODS: We performed a prospective cohort study of patients with MS and LUTS who were undergoing brain/spine MRI. Patients were administered the American Urological Association Symptom Score (AUA-SS), Medical, Epidemiologic, and Social Aspects of Aging questionnaire (MESA), and Urogenital Distress Inventory questionnaire (UDI-6), underwent Kurtzke Expanded Disability Status Scale (EDSS) scoring by a neurologist, and had their MRIs reviewed by a neuroradiologist. The relationships between symptom scores and lesion number, size, and location were analyzed. RESULTS: There were 42 patients that completed the study and 20 (48%) had one or more pontine lesions. Total AUA-SS and UDI-6 were related to multiple Short Form Health Survey (SF-36) scales and not EDSS scoring. Weak urinary stream measured on the AUA-SS (P = 0.028), and urgency incontinence measured on the MESA questionnaire (P = 0.034) were related to pontine lesion diameter. There was no difference in urinary symptoms according to the presence or absence of a pontine lesion, or according to lesion location within the pons. CONCLUSIONS: Pontine lesion size appears to be related to lower urinary tract symptoms (weak stream and urgency incontinence) in patients with MS. Therefore, CNS lesion characteristics may be able to phenotype voiding symptoms in patients with MS. Neurourol. Urodynam. 36:453-456, 2017.
Authors: Paul Browne; Dhia Chandraratna; Ceri Angood; Helen Tremlett; Chris Baker; Bruce V Taylor; Alan J Thompson Journal: Neurology Date: 2014-09-09 Impact factor: 9.910
Authors: Arnaud Charil; Alex P Zijdenbos; Jonathan Taylor; Cyrus Boelman; Keith J Worsley; Alan C Evans; Alain Dagher Journal: Neuroimage Date: 2003-07 Impact factor: 6.556
Authors: Ariana L Smith; Steven J Weissbart; Siobhán M Hartigan; Michel Bilello; Diane K Newman; Alan J Wein; Anna P Malykhina; Guray Erus; Yong Fan Journal: Neurourol Urodyn Date: 2019-11-06 Impact factor: 2.696
Authors: Jessica L Williams; Sindhu Manivasagam; Brandon C Smith; Julia Sim; Lauren L Vollmer; Brian P Daniels; John H Russell; Robyn S Klein Journal: Glia Date: 2020-01-21 Impact factor: 7.452
Authors: Giulia I Lane; Yang Mao-Draayer; Paholo Barboglio-Romo; J Quentin Clemens; Priyanka Gupta; Rod Dunn; Yongmei Qin; Anne P Cameron; John T Stoffel Journal: BMC Urol Date: 2020-05-27 Impact factor: 2.264